Survival Outcomes after Hyperthermic Intraperitoneal Chemotherapy for a First Ovarian Cancer Relapse: A Systematic Evidence-Based Review.

Jean-Marc ClasseBernard AsselainLoic CampionDominique BertonJean-Sébastien FrenelFabrice LécuruGwenael FerronLaurence GladieffCharlotte BourginCecile Loaec

Published in: Cancers (2021)

There is no strong evidence to suggest efficacy of HIPEC in improving survival of patients treated for a first relapse of ovarian cancer due to the low quality of the data.

Keyphrases

free survival
electronic health record
locally advanced
quality improvement
radiation therapy